2型糖尿病患者强化胰岛素治疗：退伍军人事务部（VA CSDM）可行性试验的启示 - Suppr | 超能文献

Intensive insulin therapy in patients with type 2 diabetes: implications of the Veterans affairs (VA CSDM) feasibility trial.

作者信息

Abraira C, McGuire D K

机构信息

Endocrinology and Diabetes Section, Hines VA Hospital, Illinois, USA.

出版信息

Am Heart J. 1999 Nov;138(5 Pt 1):S360-5. doi: 10.1016/s0002-8703(99)70036-0.

DOI:10.1016/s0002-8703(99)70036-0

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Intensive insulin therapy in patients with type 2 diabetes: implications of the Veterans affairs (VA CSDM) feasibility trial.2型糖尿病患者强化胰岛素治疗：退伍军人事务部（VA CSDM）可行性试验的启示

Am Heart J. 1999 Nov;138(5 Pt 1):S360-5. doi: 10.1016/s0002-8703(99)70036-0.

2

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.退伍军人事务部关于2型糖尿病血糖控制与并发症的合作研究（VA CSDM）。可行性试验结果。退伍军人事务部2型糖尿病合作研究。

Diabetes Care. 1995 Aug;18(8):1113-23. doi: 10.2337/diacare.18.8.1113.

3

Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.退伍军人事务部II型糖尿病血糖控制与并发症合作研究（VA CSDM）中的视网膜病变评估。一项可行性研究。

Diabetes Care. 1996 Dec;19(12):1375-81. doi: 10.2337/diacare.19.12.1375.

4

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).2型糖尿病患者对强化治疗步骤以及格列吡嗪剂量与胰岛素联合治疗的反应。退伍军人事务部血糖控制与并发症可行性研究（VA CSDM）。

Diabetes Care. 1998 Apr;21(4):574-9. doi: 10.2337/diacare.21.4.574.

5

The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.非胰岛素依赖型糖尿病强化胰岛素治疗的可行性。退伍军人事务部合作研究对非胰岛素依赖型糖尿病血糖控制及并发症的影响。

Ann Intern Med. 1996 Jan 1;124(1 Pt 2):131-5. doi: 10.7326/0003-4819-124-1_part_2-199601011-00010.

6

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.2型糖尿病血糖控制与并发症合作研究的设计：退伍军人事务部糖尿病试验

J Diabetes Complications. 2003 Nov-Dec;17(6):314-22. doi: 10.1016/s1056-8727(02)00277-5.

7

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.退伍军人事务部糖尿病可行性试验中的心血管事件及其相关因素。退伍军人事务部II型糖尿病血糖控制与并发症合作研究。

Arch Intern Med. 1997 Jan 27;157(2):181-8.

8

Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.在一个肝细胞核因子1A-成年发病型糖尿病队列中，磺脲类药物治疗维持成功且糖尿病并发症发生率低。

Diabet Med. 2016 Jul;33(7):976-84. doi: 10.1111/dme.12992. Epub 2015 Nov 17.

9

Postprandial hyperglycaemia--its importance and implications.

Int J Clin Pract Suppl. 1999 Jul;104:3-7; discussion 18-20.

10

Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.瑞格列奈与格列吡嗪治疗2型糖尿病的比较：一项为期1年的多中心研究。

Diabet Med. 2001 May;18(5):395-401. doi: 10.1046/j.1464-5491.2001.00490.x.

引用本文的文献

1

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.用于治疗糖尿病和慢性肾脏病患者的胰岛素及降糖药物。

Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2.

2

Glucose targets for preventing diabetic kidney disease and its progression.预防糖尿病肾病及其进展的血糖目标。

Cochrane Database Syst Rev. 2017 Jun 8;6(6):CD010137. doi: 10.1002/14651858.CD010137.pub2.